- Home
- NWBI vs ARQT Comparison
NWBI vs ARQT Comparison
Compare NWBI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- ARQT
- Stock Information
- Founded
- NWBI 1896
- ARQT 2016
- Country
- NWBI United States
- ARQT United States
- Employees
- NWBI N/A
- ARQT N/A
- Industry
- NWBI Major Banks
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- NWBI Finance
- ARQT Health Care
- Exchange
- NWBI Nasdaq
- ARQT Nasdaq
- Market Cap
- NWBI 1.8B
- ARQT 2.1B
- IPO Year
- NWBI N/A
- ARQT 2020
- Fundamental
- Price
- NWBI $11.99
- ARQT $24.38
- Analyst Decision
- NWBI Buy
- ARQT Strong Buy
- Analyst Count
- NWBI 2
- ARQT 7
- Target Price
- NWBI $15.00
- ARQT $22.17
- AVG Volume (30 Days)
- NWBI 898.9K
- ARQT 2.5M
- Earning Date
- NWBI 10-27-2025
- ARQT 10-28-2025
- Dividend Yield
- NWBI 6.67%
- ARQT N/A
- EPS Growth
- NWBI 14.20
- ARQT N/A
- EPS
- NWBI 0.87
- ARQT N/A
- Revenue
- NWBI $564,562,000.00
- ARQT $317,929,000.00
- Revenue This Year
- NWBI $7.26
- ARQT $85.27
- Revenue Next Year
- NWBI $13.90
- ARQT $30.70
- P/E Ratio
- NWBI $13.83
- ARQT N/A
- Revenue Growth
- NWBI 15.71
- ARQT 129.21
- 52 Week Low
- NWBI $10.75
- ARQT $8.45
- 52 Week High
- NWBI $15.42
- ARQT $27.08
- Technical
- Relative Strength Index (RSI)
- NWBI 45.88
- ARQT 64.85
- Support Level
- NWBI $11.54
- ARQT $19.60
- Resistance Level
- NWBI $11.86
- ARQT $27.08
- Average True Range (ATR)
- NWBI 0.25
- ARQT 1.25
- MACD
- NWBI -0.04
- ARQT 0.21
- Stochastic Oscillator
- NWBI 41.86
- ARQT 63.91
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.